NO984782L - Nye indikasjoner for anvendelse som medikamenter av multipotente parapox immunitets induseringsmiddel fra attenuerte, ikke-immunogene poxviruser eller parapox viruser - Google Patents

Nye indikasjoner for anvendelse som medikamenter av multipotente parapox immunitets induseringsmiddel fra attenuerte, ikke-immunogene poxviruser eller parapox viruser

Info

Publication number
NO984782L
NO984782L NO984782A NO984782A NO984782L NO 984782 L NO984782 L NO 984782L NO 984782 A NO984782 A NO 984782A NO 984782 A NO984782 A NO 984782A NO 984782 L NO984782 L NO 984782L
Authority
NO
Norway
Prior art keywords
parapox
viruses
multipotent
attenuated
drugs
Prior art date
Application number
NO984782A
Other languages
English (en)
Other versions
NO984782D0 (no
NO322176B1 (no
Inventor
Anton Mayr
Original Assignee
Anton Mayr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anton Mayr filed Critical Anton Mayr
Publication of NO984782D0 publication Critical patent/NO984782D0/no
Publication of NO984782L publication Critical patent/NO984782L/no
Publication of NO322176B1 publication Critical patent/NO322176B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO19984782A 1996-04-15 1998-10-14 Anvendelse av pox inducere omfattende en kombinasjon av henholdsvis flere pox virus og parapox virus for fremstilling av medikamentet for prefinal tumorterapi for a lindre smerte og optimalisere velbefinnende til pasienter. NO322176B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19614810 1996-04-15
PCT/DE1997/000761 WO1997038724A1 (de) 1996-04-15 1997-04-14 Neue indikationen für die verwendung von multipotenten paramunitätsinducern aus attenuierten, nicht-immunogenen pockenviren oder parapockenviren als arzneimittel

Publications (3)

Publication Number Publication Date
NO984782D0 NO984782D0 (no) 1998-10-14
NO984782L true NO984782L (no) 1998-12-15
NO322176B1 NO322176B1 (no) 2006-08-21

Family

ID=7791302

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984782A NO322176B1 (no) 1996-04-15 1998-10-14 Anvendelse av pox inducere omfattende en kombinasjon av henholdsvis flere pox virus og parapox virus for fremstilling av medikamentet for prefinal tumorterapi for a lindre smerte og optimalisere velbefinnende til pasienter.

Country Status (20)

Country Link
US (1) US6162600A (no)
EP (1) EP0885013B1 (no)
JP (1) JP3568208B2 (no)
KR (1) KR100302994B1 (no)
CN (1) CN1165343C (no)
AT (1) ATE203678T1 (no)
AU (1) AU706729B2 (no)
BR (1) BR9708679A (no)
CA (1) CA2251690C (no)
DE (2) DE59704194D1 (no)
DK (1) DK0885013T3 (no)
ES (1) ES2125846T3 (no)
GR (1) GR3037049T3 (no)
HU (1) HU224308B1 (no)
NO (1) NO322176B1 (no)
NZ (1) NZ332243A (no)
PL (1) PL329353A1 (no)
PT (1) PT885013E (no)
SI (1) SI0885013T1 (no)
WO (1) WO1997038724A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2003104522A (ru) * 2000-07-11 2004-06-27 Байер Акциенгезельшафт (De) Применение штаммов parapoxvirus (парапокс-вируса) против органофиброзов
GB2381454B8 (en) * 2000-07-11 2007-10-23 Aicuris Gmbh & Co Kg Use of strains of Parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer
DE10122233A1 (de) * 2000-07-11 2002-01-24 Bayer Ag Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen
US6844000B2 (en) 2001-12-07 2005-01-18 Bayer Pharmaceuticals Corporation Use of Parapox B2L protein to treat cancer and modify immune responses
CA2573204C (en) * 2004-07-13 2011-09-20 Aicuris Gmbh & Co. Kg Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids
DE102004045758A1 (de) * 2004-09-21 2006-04-06 Toximed Gmbh Pharmazeutischer Wirkstoff gegen das HIV-Syndrom
DE102005027956B4 (de) * 2005-06-16 2009-10-22 Mayr, Anton, Prof. Dr. Dr. h.c. mult. Hochattenuierte Poxvirusstämme, Verfahren zu ihrer Herstellung und deren Verwendung als Paramunitätsinducer oder zur Herstellung von Vektor-Vakzinen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3504940C2 (de) * 1984-02-17 1997-11-06 Bayer Ag Multipotente Paramunitätsmediatoren, Verfahren zu ihrer Herstellung und diese Mediatoren enthaltende Arzneimittel
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
EP0885013A1 (de) 1998-12-23
JP2000501114A (ja) 2000-02-02
HUP9901299A2 (hu) 1999-07-28
AU2885897A (en) 1997-11-07
US6162600A (en) 2000-12-19
KR100302994B1 (ko) 2001-11-30
PL329353A1 (en) 1999-03-29
SI0885013T1 (no) 2001-12-31
BR9708679A (pt) 2000-01-04
GR3037049T3 (en) 2002-01-31
KR20000005479A (ko) 2000-01-25
NO984782D0 (no) 1998-10-14
CN1165343C (zh) 2004-09-08
NZ332243A (en) 2000-10-27
HU224308B1 (hu) 2005-07-28
JP3568208B2 (ja) 2004-09-22
WO1997038724A1 (de) 1997-10-23
ATE203678T1 (de) 2001-08-15
CA2251690C (en) 2005-11-08
NO322176B1 (no) 2006-08-21
DK0885013T3 (da) 2001-11-05
HUP9901299A3 (en) 2000-03-28
ES2125846T3 (es) 2001-12-16
ES2125846T1 (es) 1999-03-16
CA2251690A1 (en) 1997-10-23
CN1215996A (zh) 1999-05-05
EP0885013B1 (de) 2001-08-01
AU706729B2 (en) 1999-06-24
PT885013E (pt) 2002-01-30
DE59704194D1 (de) 2001-09-06
DE19780300D2 (de) 1999-06-17

Similar Documents

Publication Publication Date Title
NO20032309D0 (no) Modifisert variant av vaccinia ankaravirus
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
DK184186A (da) Terapeutisk praeparat til behandling af virussygdomme
ATE161055T1 (de) Polymorphie des glykoproteins iiia der menschlichen blutplättchenmembran und diagnostische applikation davon
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
PT933993E (pt) Compostos de ciclopentano substituidos, uteis como inibidores de neuraminidase
MX9704777A (es) Compuestos espiro tetraciclicos, procedimiento para su preparacion y composiciones que los contienen.
DE3688038D1 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
DK208987D0 (da) Polypeptider og antistoffer, som er karakteristiske for papillomvirus, og deres anvendelse ved diagnostiske metoder og i vacciner
NO984782L (no) Nye indikasjoner for anvendelse som medikamenter av multipotente parapox immunitets induseringsmiddel fra attenuerte, ikke-immunogene poxviruser eller parapox viruser
FI102293B1 (fi) Ihmisen interleukiini-3:n molekulaarinen kloonaus ja ilmentäminen
ES2176216T3 (es) Particulas de ceramica y su preparacion.
NO893135L (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
ES2056833T3 (es) Sondas de papilomavirus y procedimiento de diagnostico in vitro de infecciones por papilomavirus.
DE69131984D1 (de) Das für das pferde herpes-virus typ 1 glykoprotein d, kodierende gen, sein genprodukt, antikörper und ihre verwendung
ATE43498T1 (de) Pyrethroid enthaltende pharmazeutische zubereitungen.
SE399182B (sv) Anordning for vermning och befuktning av andningsgas, serskilt andningsgas vid medicinska apparater
Guze Suicide, hysteria, and conversion symptoms
IT8844210A0 (it) Sistema per la riduzione della dispersione, per la conservazione e l'uniforme distribuzione del calore nel pentolame da cucina
RO99844B1 (ro) Medicament pentru tratamentul gripei si virozelor respiratorii
ITAG940002A0 (it) Apparecchio ossigenatore e purificatore del sangue infetto da virus
SU1565027A1 (ru) Инактиватор вируса западного нила
DK98788D0 (da) Benzylaminoaryl-dihydropyridinlactoner, fremgangmsaade til deres fremstilling samt deres anvendelse som laegemidler
IT8144004A0 (it) Dispositivo atto a controllare la regolare erogazione di soluzione somministrata al paziente mediante fleboclisi e a segnalare ogni possibile inconveniente